Increasing Cases of Retroperitoneal Fibrosis After Covid-19: Case Report, Did She Die Retroperitoneal Fibrosis or Cancer?
No Thumbnail Available
Date
2024-03
Authors
Deniz, Gulnihal
Cakir, Murteza
Bilgin Akyagci, Serpil
Journal Title
Journal ISSN
Volume Title
Publisher
Emergency Medicine Physicians Assoc Turkey
Abstract
This case report details the unfortunate journey of a 59-year-old breast cancer survivor who developed secondary Retroperitoneal Fibrosis (RPF) in 2022. Despite diligent treatment efforts, her condition took a devastating turn when, in June 2023, she was diagnosed not only with persistent RPF but also with advanced liver, omental, and duodenal cancer. Tragically, her condition deteriorated rapidly, leading to her passing on day 41 following her presentation. This case underscores the challenges of diagnosing and treating RPF. It highlights the importance of considering cancer development in advanced RPF cases that do not respond to treatment, often leaving limited options for effective intervention.
Description
Emerging Sources Citation Index (ESCI)
Keywords
Retroperitoneal fibrosis , liver cancer , metastasis , steroid , azathioprine
Citation
Deniz, G., Çakır, M., & Bilgin Akyagci, S. (2024). Increasing Cases of Retroperitoneal Fibrosis After Covid-19: Case Report, Did She Die Retroperitoneal Fibrosis or Cancer?. Journal of Emergency Medicine Case Reports, 15(1), 12-15. https://doi.org/10.33706/jemcr.1419408
